Philadelphia Mag

Excision BioTherapeutics Has Secured $60M to Proceed with HIV Clinical Trial

The Philly-based biotech company will begin human testing of EBT-101, a CRISPR-based gene editing construct developed at Temple’s Lewis Katz School of Medicine. According to Excision’s CEO, Daniel ...
Healio

Narrow excision shows positive results in treatment of melanoma near critical areas

Please provide your email address to receive an email when new articles are posted on . 5-mm margins do not increase the risk of melanoma-specific mortality or local recurrence compared with 10-mm ...
Medscape

Excision With 5-mm Margins Evaluated in Small Melanoma In Situ

Patients with small melanoma in situ (MIS) on low-risk body sites that was managed with 5-mm margins had a local recurrence rate of 0.9%, results from a retrospective case series from a single ...
ascopubs.org

Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort Eligible patients underwent lumpectomy for DCIS that was mammogram detected, size ≤ 2.5 cm, ...